Skip to content
City PM
  • Germany
  • France
  • Europe
  • Markets
  • Business
  • Opinion
  • Germany
  • France
  • Europe
  • Markets
  • Business
  • Opinion
Thursday 01 August 2024 10:35 am  |  Updated:  Thursday 01 August 2024 10:37 am

Haleon posts profit bump on back of power brands

By: Amber Murray

Retail Reporter

Add as a preferred source on Google
Haleon reports mid-single-digit growth, announces share buybacks
Haleon reports mid-single-digit growth, announces share buybacks

Consumer healthcare company Haleon has reported a four per cent rise in pre-tax earnings amid strong demand for its power brands despite a soft market for at-home healthcare in the US.

Organic profit rose by 11 per cent in the six months ended June 30, with gross margin expansion due to “lower cost inflation and productivity savings”, the company said. This was partly offset by strong brand investment.

Shares in Haleon, which makes household names such as Sensodyne toothpaste, Panadol painkillers and Eno antacids, jumped about two per cent in early trades.

Reported operating profit rose by 0.9 per cent to £1.151m. It was impacted by “restructuring costs including the productivity programme,” the company said.

The healthcare company separately announced a share buyback programme of up to £185m. It is the remainder of the £500m allocated to share buybacks in 2024, Haleon said. HSBC will purchase the shares.

“Haleon reported a good first half, with solid organic revenue growth and strong organic operating profit growth, demonstrating that our strategy is delivering. Whilst as expected, comparatives impacted results, revenue growth accelerated in the second quarter with improved volume mix.

“We continue to implement change to become more agile and competitive, with the recent news of
the divestment of the NRT business outside of the US as another example of this,” chief executive officer Brian McNamara said.

The company saw particular growth in its “power brands”, oral health and vitamins. Toothpaste products Sensodyne and Parodontax as well as with multi-vitamin product Centrum both achieved double-digit growth.

“Looking ahead, we are well positioned to deliver on our full-year organic revenue growth guidance and
now expect high-single digit organic profit growth. Given the successful delivery of the strategy to date
Haleon is also well placed over the medium term,” McNamara said.

Analysts expect full-year profit growth of 7.8 per cent, according to a company-compiled poll.

Haleon also announced a dividend of 2p per share to be paid on September 19.

Read more

One in Three Western Consumers Now Buy Products Discovered on Social Platforms as AI Reshapes Commerce, According to NIQ

Share this article

  • Facebook
  • X
  • LinkedIn
  • WhatsApp
  • Email

Similarly tagged content:

Sections

  • News

Categories

  • Business

People & Organisations

  • Eno
  • Haleon
  • healthcare
  • Panadol
  • Sensodyne
  • Share buybacks

Trending Articles

  • Top Burnham adviser calls for capital gains and inheritance tax hikes

  • Clarkson’s Farm and why businesses must stop blaming the weather

  • Two solicitors linked to Post Office scandal charged with misconduct

  • Lloyd’s deputy chair: The City is a club in the best sense

  • A meeting with the breakfast king of Mayfair

More from City PM

  • One in Three Western Consumers Now Buy Products Discovered on Social Platforms as AI Reshapes Commerce, According to NIQ

    Business Wire
  • NIKE, Inc. Announces Planned CFO Transition

    Business Wire
  • AI infrastructure boom helps power Halma to record sales and profit

    Tech
    Halma's revenue was boosted by its environmental and safety businesses.
  • Semble Secures £30M Series C Investment Led by Revaia to Expand Europe’s Connected Healthcare Platform

    Business Wire
  • AIRS Medical Welcomes Strategic Growth Investment from TA Associates to Accelerate Global Growth in AI-Powered MRI Solutions

    Business Wire
  • Real Chemistry Unifies Omnichannel Offering as Real Chemistry Media, a Technology-led, Healthcare-focused Practice of the Future

    Business Wire
  • Babcock predicts global government defence spending spree after hit to profit

    Investing
    Babcock is a member of the FTSE 100.
  • Gold prices glitter amid geopolitical uncertainty

    Investing
    Gold jewelry displayed in Indian market as gold price hits record $5,097 amid Trump tariff turmoil and investor demand

City PM — European politics, business and analysis.

Europe

  • Germany
  • France
  • Europe
  • UK & Ireland

Topics

  • Business
  • Markets
  • AI
  • Technology
  • Opinion
  • Energy

More

  • Politics
  • Economics
  • Fintech
  • Legal
  • Sport
  • Life

Company

  • About City PM
  • Editorial Policy
  • Corrections
  • Contact
  • Terms of Use
  • Privacy Policy
  • Cookie Policy
© 2026 City PM · Published by CityPM Media, Bahnhofstrasse 65, 8001 Zürich, Switzerland
About · Editorial Policy · Corrections · Contact · Privacy